PBS subsidy arrangements for cefalexin SSSI

Page last updated: 21 December 2022

The Department of Health and Aged Care has made amendments to the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021. This is following the issuance of the Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Cefalexin) Instrument 2022, which allows pharmacists to supply different strengths of the drug cefalexin in the manner of administration oral at equivalent doses for the duration of the shortage, provided specified conditions are met. Further information about the substitution is available on the PBS Medicine Shortages page.